These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22009001)

  • 1. Cognate Th2-B cell interaction is essential for the autoantibody production in pemphigus vulgaris.
    Zhu H; Chen Y; Zhou Y; Wang Y; Zheng J; Pan M
    J Clin Immunol; 2012 Feb; 32(1):114-23. PubMed ID: 22009001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
    Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
    Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
    Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
    J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.
    Tsunoda K; Ota T; Suzuki H; Ohyama M; Nagai T; Nishikawa T; Amagai M; Koyasu S
    Eur J Immunol; 2002 Mar; 32(3):627-33. PubMed ID: 11857336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single helper T cell clone is sufficient to commit polyclonal naive B cells to produce pathogenic IgG in experimental pemphigus vulgaris.
    Takahashi H; Kuwana M; Amagai M
    J Immunol; 2009 Feb; 182(3):1740-5. PubMed ID: 19155523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris.
    Takahashi H; Amagai M; Nishikawa T; Fujii Y; Kawakami Y; Kuwana M
    J Immunol; 2008 Jul; 181(2):1526-35. PubMed ID: 18606708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles.
    Veldman C; Stauber A; Wassmuth R; Uter W; Schuler G; Hertl M
    J Immunol; 2003 Jan; 170(1):635-42. PubMed ID: 12496453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aire-dependent thymic expression of desmoglein 3, the autoantigen in pemphigus vulgaris, and its role in T-cell tolerance.
    Wada N; Nishifuji K; Yamada T; Kudoh J; Shimizu N; Matsumoto M; Peltonen L; Nagafuchi S; Amagai M
    J Invest Dermatol; 2011 Feb; 131(2):410-7. PubMed ID: 21048786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the T cells that are potentially involved in autoantibody production in pemphigus vulgaris.
    Hertl M; Riechers R
    J Dermatol; 1999 Nov; 26(11):748-52. PubMed ID: 10635617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris.
    Yokoyama T; Matsuda S; Takae Y; Wada N; Nishikawa T; Amagai M; Koyasu S
    Int Immunol; 2011 Jun; 23(6):365-73. PubMed ID: 21525154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease.
    Rizzo C; Fotino M; Zhang Y; Chow S; Spizuoco A; Sinha AA
    Clin Exp Dermatol; 2005 Sep; 30(5):535-40. PubMed ID: 16045688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desmoglein 3-specific CD4+ T cells induce pemphigus vulgaris and interface dermatitis in mice.
    Takahashi H; Kouno M; Nagao K; Wada N; Hata T; Nishimoto S; Iwakura Y; Yoshimura A; Yamada T; Kuwana M; Fujii H; Koyasu S; Amagai M
    J Clin Invest; 2011 Sep; 121(9):3677-88. PubMed ID: 21821914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pemphigus vulgaris and its active disease mouse model.
    Amagai M
    Curr Dir Autoimmun; 2008; 10():167-81. PubMed ID: 18460885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of desmoglein-3-specific T cell response and pathogenic antibody generation in mice.
    Pan M; Zhou Y; Li W; Zheng J
    Immunol Lett; 2008 Oct; 120(1-2):6-13. PubMed ID: 18634826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
    Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
    J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris.
    Lin MS; Swartz SJ; Lopez A; Ding X; Fernandez-Vina MA; Stastny P; Fairley JA; Diaz LA
    J Clin Invest; 1997 Jan; 99(1):31-40. PubMed ID: 9011573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting inducible costimulator expressed on CXCR5
    Kim AR; Han D; Choi JY; Seok J; Kim SE; Seo SH; Takahashi H; Amagai M; Park SH; Kim SC; Shin EC; Kim JH
    J Allergy Clin Immunol; 2020 Nov; 146(5):1070-1079.e8. PubMed ID: 32311391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T lymphocytes from a subset of patients with pemphigus vulgaris respond to both desmoglein-3 and desmoglein-1.
    Lin MS; Swartz SJ; Lopez A; Ding X; Fairley JA; Diaz LA
    J Invest Dermatol; 1997 Dec; 109(6):734-7. PubMed ID: 9406813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadsorption of Desmoglein-3-Specific IgG Abolishes the Blister-Inducing Capacity of Pemphigus Vulgaris IgG in Neonatal Mice.
    Hofrichter M; Dworschak J; Emtenani S; Langenhan J; Weiß F; Komorowski L; Zillikens D; Stöcker W; Probst C; Schmidt E; Goletz S
    Front Immunol; 2018; 9():1935. PubMed ID: 30233569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris.
    Schmidt T; Willenborg S; Hünig T; Deeg CA; Sonderstrup G; Hertl M; Eming R
    Exp Dermatol; 2016 Apr; 25(4):293-8. PubMed ID: 26661498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.